About Severe combined immunodeficiency due to complete RAG1/2 deficiency
Severe combined immunodeficiency due to complete RAG1/2 deficiency is a rare disease catalogued by Orphanet (ORPHA:331206). It is associated with the RAG1, RAG2 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Severe combined immunodeficiency due to complete RAG1/2 deficiency trials.
Search ClinicalTrials.gov for "Severe combined immunodeficiency due to complete RAG1/2 deficiency" or filter by Orphanet code ORPHA:331206 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Severe combined immunodeficiency due to complete RAG1/2 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Severe combined immunodeficiency due to complete RAG1/2 deficiency. Updated daily.